search
Back to results

Study of Obeldesivir in Nonhospitalized Participants With COVID-19 (OAKTREE)

Primary Purpose

COVID-19

Status
Recruiting
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Obeldesivir
Obeldesivir Placebo
Sponsored by
Gilead Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for COVID-19

Eligibility Criteria

12 Years - 64 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Key Inclusion Criteria: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection confirmed, ≤ 3 days before randomization, by polymerase chain reaction (PCR), rapid antigen test, or an approved alternative assay. Serologic tests will not be accepted. Willing and able to complete the coronavirus disease 19 (COVID-19) symptom questionnaire prior to first dose and daily throughout the study period. Initial onset of COVID-19 signs/symptoms ≤ 3 days before randomization with ≥ 2 of the following targeted symptoms, at moderate or higher severity, present at randomization. Stuffy or runny nose. Sore throat. Shortness of breath (difficulty breathing). Cough. Low energy or tiredness. Muscle or body aches. Headache. Chills or shivering. Feeling hot or feverish. Not currently hospitalized or requiring hospitalization. Key Exclusion Criteria: Any risk factors for progression to severe disease. Planning to receive a direct acting antiviral or monoclonal antibody against SARS-CoV-2 for the treatment of COVID-19. Received any direct acting antiviral drug or monoclonal antibody against SARS-CoV-2 for the treatment of COVID-19 < 28 days or < 5 half-lives, whichever is longer, before randomization. Received any convalescent COVID-19 plasma or other antibody-based anti-SARS-CoV-2 prophylaxis at any time prior to study entry. Received an COVID-19 vaccine (including booster dose) < 120 days before randomization. Self-reported COVID-19 diagnosis < 120 days before randomization. Anticipated need for hospitalization < 48 hours after randomization. New oxygen requirement < 24 hours before randomization. Known influenza, or any other suspected or confirmed concurrent active systemic infection other than COVID-19 that may interfere with the evaluation of response to the study drug. Known history of chronic liver disease, limited to cirrhosis, nonalcoholic steatohepatitis, alcoholic liver disease, and autoimmune hepatitis. Undergoing dialysis, or known history of chronic kidney disease. Persistent symptoms from previous COVID-19 illness that may interfere with the evaluation of response to the study drug. Pregnant or breastfeeding. Unwilling to use protocol-mandated contraception. Any other factor, including inability to complete the patient-reported outcome (PRO) questionnaire for the primary endpoint, making the individual, in the opinion of the investigator, unsuitable to participate in the study. Concurrent participation/enrollment in a separate therapeutic clinical study. Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Sites / Locations

  • EmVenio Research
  • Cullman Clinical Trials
  • Velocity Clinical Research
  • Cahaba Research, Inc.
  • Institute for Liver Health dba Arizona Clinical Trials
  • Absolute Clinical Research
  • Headlands Research - Scottsdale
  • Epic Medical Research-Surprise
  • The Institute for Liver Health dba Arizona Liver Health
  • Advanced Research Center, Inc.
  • Franco Felizarta, MD
  • Velocity Clinical Research, Banning (IP Delivery and Administering Location)
  • Benchmark Research
  • El Centro Regional Medical Center
  • Ascada Research
  • Velocity Clinical Research
  • IMAX Clinical Trials, LLC
  • Om Research LLC
  • Biopharma Informatic, LLC
  • Ruane Clinical Research Group Inc.
  • L.A. Universal Research Center, INC.
  • Amicis Research Center
  • Valley Clinical TrialsRecruiting
  • Fomat Medical Research
  • Paradigm Clinical Research
  • Clinica de Salud del Valle de Salinas
  • CRMD Research
  • Wr-Whcr, Llc
  • Zuckerberg San Francisco General Hospital
  • Clearview Medical Research, LLC
  • EmVenio Research
  • Med Partners, Inc. dba Premiere Medical Center of Burbank, Inc.
  • Georgetown University Medical CenterRecruiting
  • Encore Medical Research of Boynton Beach LLC
  • Palm Harbor Dermatology d/b/a TrueBlue Clinical Research
  • Innovative Research of West Florida, Inc
  • Prestige Clinical Research Center Inc
  • Beautiful Minds Clinical Research Center
  • Midland Florida Clinical Research Center, LLC
  • Vital Care Research
  • UHC Research, LLC
  • Proactive Clinical Research,LLC
  • Midway Immunology and Research Center
  • Evolution Clinical Trials, INC
  • Qway Research LLC
  • AGA Clinical Trials
  • Inpatient Research Clinic- Facility and Drug Shipment
  • Research in Miami
  • 3Sync, LLC
  • Best Quality Research, Inc.
  • Doral Medical Research
  • Innovative Health
  • Encore Medical Research, LLC
  • Wr-Msra, Llc
  • Clinical Site Partners, LLC dba Flourish Research
  • Pro-Care Research Center, Corp.
  • Essential Clinical Research
  • Palm Springs Community Health Center
  • Angels Clinical Research Institute
  • Quality Research of South Florida
  • Advance Clinical Research Group
  • Med-Care Research, Corp
  • Southern Clinical Research LLC
  • LCC Medical Research Institute, LLC
  • Universal Medical and Research Center, LLC.
  • CCM Clinical Research Group, LLC
  • Global Health Clinical Trials Corp
  • Retreat Medical Research
  • Verus Clinical Research, Corp
  • Clinical Trial Services, CorpRecruiting
  • Continental Clinical Research
  • Dynamic Medical Research, LLC
  • Nuren Medical & Research Center
  • Advanced Care and Clinical Trials, LLC
  • Bioclinical Research Alliance Inc.
  • Cordova Research Institute, Inc
  • D&H National Research Centers, INC
  • Florida International Medical Research
  • Miami Clinical Research
  • Allied Biomedical Research Institute
  • Diverse Clinical Research, LLC
  • P&S Research, LLC.
  • ProLive Medical Research, Corp
  • Entrust Clinical Research
  • Links Clinical Trials LLC
  • Reed Medical Research Corp
  • MedBio Trials LLC
  • Clinical Site Partners, LLC dba Flourish Research
  • Nuovida Research Center Corp
  • Phoenix Research Center, LLC
  • Oceanic Research Group
  • Accel Research Sites Network - St. Pete-Largo Clinical Research Unit
  • Digestive and Liver Center of Florida
  • Ormond Beach Clinical Research
  • Castillo Torres, MD PA
  • Family Clinical Trials, LLC
  • USPA Advance Concept Medical Research Group, LLC
  • Precision Clinical Research
  • Angels Clinical Research Institute
  • Precision Research Center
  • Santos Research Center, CORP
  • Midway Specialty Care Center
  • Triple O Research Institute, P.A.
  • Encore Medical Reseach of Weston, LLC
  • Clinical Site Partners, LLC dba Flourish Research
  • EmVenio Research
  • Agile Clinical Research Trials, LLC
  • Covenant Pulmonary Critical Care Research Institute
  • Accel Research Sites Network - Cardiology Care Clinic
  • Velocity Clinical Research
  • Metro Infectious Disease Consultants
  • MediSphere Medical Research Center, LLC
  • Aliance for multispecialty Research, LLC
  • Velocity Clinical Research
  • Velocity Clinical Research
  • Tulane University School of Medicine
  • Velocity Clinical Research
  • Velocity Clinical Research
  • Headlands Research
  • Hannibal Regional Healthcare System, Inc.
  • Mercury Street Medical Group LLC
  • Velocity Clinical Research, Inc.
  • Saint Michael's Medical Center
  • Velocity Clinical Research
  • University of New Mexico Health Sciences Center
  • Lincoln Hospital
  • Prime Global Research Inc
  • James J. Peters VA Medical Center
  • Velocity Clinical Research
  • Icahn School of Medicine at Mount Sinai
  • Velocity Clinical Research, Inc.
  • Velocity Clinical Research
  • Shelby Clinical Research, LLC
  • The Brody School of Medicine at East Carolina University
  • Monroe Biomedical Research
  • M3 Wake Research, Inc.
  • Carolina Research Center, Inc.
  • Atrium Health Wake Forest Baptist
  • The Lindner Research Center at The Christ Hospital
  • STAT Research
  • Velocity Clinical Research
  • Frontier Clinical Research, LLC
  • Velocity Clinical Research
  • Clinovacare Medical Research Center
  • WR-ClinSearch, LLC
  • PharmaTex Research
  • Central Texas Clinical Research
  • St Hope Foundation, Inc.
  • PanAmerican Clinical Research
  • Velocity Clinical Research
  • WR-Global Medical Research, LLC
  • Baylor University Medical Center
  • Premier Pulmonary Critical Care and Sleep Medicine
  • Care United Research, LLC
  • EmVenio Research
  • Trio Clinical Trials, LLC.
  • HDH Research Inc.
  • Synergy Groups Medical LLC
  • Diversified Medical Practices
  • Next Level Urgent Care
  • Synergy Groups Medical LLC
  • The Crofoot Research Center, INC.
  • Zion Research/Zion Urgent Care Clinic
  • Milton Haber, MD
  • SMS Clinical Research, LLC
  • Synergy Groups Medical LLC
  • Village Health Partners
  • Village Health Partners
  • North Texas Family Medicine
  • Epic Medical Research, LLC
  • STAAMP Research LLC
  • VIP Trials
  • ClinPoint Trials, LLC
  • Tranquil Clinical Research
  • Bountiful Internal Medicine
  • Velocity Clinical Research, Salt Lake City
  • Alliance for Multispecialty Research, LLC
  • Frontier Clinical Research, LLC
  • Hamilton Medical Research Group
  • Kanagawa Himawari ClinicRecruiting
  • Medical corporation Shirayurikai Swing Nozaki ClinicRecruiting
  • Sato ClinicRecruiting
  • Tokyo Shinagawa Hospital Social Medical Corporation Association Tokyokyojuno-kaiRecruiting
  • Proyecto ACTU

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Obeldesivir

Obeldesivir Placebo

Arm Description

Participants will receive obeldesivir 350 mg twice daily for 5 days.

Participants will receive obeldesivir placebo twice daily for 5 days.

Outcomes

Primary Outcome Measures

Time to Coronavirus Disease 2019 (COVID-19) Symptom Alleviation by Day 29
Percentage of Participants Experiencing Treatment-emergent Adverse Events (TEAEs)
Percentage of Participants Experiencing Laboratory Abnormalities
Percentage of Participants Experiencing Serious Adverse Events (SAEs) and Adverse Events (AEs) Leading to Study Drug Discontinuation

Secondary Outcome Measures

Time to COVID-19 Symptom Resolution by Day 29
Proportion of Participants with COVID-19 related Medically Attended Visits (MAVs) or All-cause Death by Day 29
Proportion of Participants with Moderate Relapse of COVID-19 Symptoms by Day 29
Proportion of Participants with COVID-19 related Hospitalization or All-cause Death by Day 29
Change from Baseline in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nasal Swab Viral Load at Day 5
Time to Antigen Negativity
Proportion of Participants with Viral Antigen Rebound
Plasma Concentrations of GS-441524 (Metabolite of Obeldesivir)
Pharmacokinetic (PK) Parameter: AUCtau of GS-441524
AUCtau is defined as the area under the concentration versus time curve over the dosing interval
PK Parameter: Ctau of GS-441524
Ctau is defined as the observed drug concentration at the end of the dosing interval
PK Parameter: Cmax of GS-441524
Cmax is defined as the maximum observed plasma concentration of drug
Proportion of Participants with Relapse of COVID-19 Symptoms by Day 29

Full Information

First Posted
February 3, 2023
Last Updated
October 18, 2023
Sponsor
Gilead Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT05715528
Brief Title
Study of Obeldesivir in Nonhospitalized Participants With COVID-19
Acronym
OAKTREE
Official Title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-5245 for the Treatment of COVID-19 in Nonhospitalized Participants
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 8, 2023 (Actual)
Primary Completion Date
June 2024 (Anticipated)
Study Completion Date
August 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Gilead Sciences

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The goal of this clinical study is to test if obeldesivir (formerly GS-5245) is safe and effective for the treatment of coronavirus disease 2019 (COVID-19) in participants who have a standard risk of developing severe illness. This study will also measure how much obeldesivir gets into the blood and how long it takes for the body to get rid of it.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COVID-19

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Masking Description
Participants, personnel directly involved in the conduct of study, and sponsor will not know the treatment participants received.
Allocation
Randomized
Enrollment
1900 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Obeldesivir
Arm Type
Experimental
Arm Description
Participants will receive obeldesivir 350 mg twice daily for 5 days.
Arm Title
Obeldesivir Placebo
Arm Type
Placebo Comparator
Arm Description
Participants will receive obeldesivir placebo twice daily for 5 days.
Intervention Type
Drug
Intervention Name(s)
Obeldesivir
Other Intervention Name(s)
GS-5245
Intervention Description
Tablet administered orally without regard to food.
Intervention Type
Drug
Intervention Name(s)
Obeldesivir Placebo
Intervention Description
Tablet administered orally without regard to food.
Primary Outcome Measure Information:
Title
Time to Coronavirus Disease 2019 (COVID-19) Symptom Alleviation by Day 29
Time Frame
First dose date up to Day 29
Title
Percentage of Participants Experiencing Treatment-emergent Adverse Events (TEAEs)
Time Frame
First dose date up to Day 5 plus 30 days
Title
Percentage of Participants Experiencing Laboratory Abnormalities
Time Frame
First dose date up to Day 5 plus 30 days
Title
Percentage of Participants Experiencing Serious Adverse Events (SAEs) and Adverse Events (AEs) Leading to Study Drug Discontinuation
Time Frame
First dose date up to Day 5 plus 30 days
Secondary Outcome Measure Information:
Title
Time to COVID-19 Symptom Resolution by Day 29
Time Frame
Day 1 up to 29
Title
Proportion of Participants with COVID-19 related Medically Attended Visits (MAVs) or All-cause Death by Day 29
Time Frame
Up to Day 29
Title
Proportion of Participants with Moderate Relapse of COVID-19 Symptoms by Day 29
Time Frame
Up to Day 29
Title
Proportion of Participants with COVID-19 related Hospitalization or All-cause Death by Day 29
Time Frame
Up to Day 29
Title
Change from Baseline in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nasal Swab Viral Load at Day 5
Time Frame
Baseline, Day 5
Title
Time to Antigen Negativity
Time Frame
Day 1 up to Day 29
Title
Proportion of Participants with Viral Antigen Rebound
Time Frame
First dose date up to Day 29
Title
Plasma Concentrations of GS-441524 (Metabolite of Obeldesivir)
Time Frame
Day 1, Day 3, and Day 5
Title
Pharmacokinetic (PK) Parameter: AUCtau of GS-441524
Description
AUCtau is defined as the area under the concentration versus time curve over the dosing interval
Time Frame
Day 1, Day 3, and Day 5
Title
PK Parameter: Ctau of GS-441524
Description
Ctau is defined as the observed drug concentration at the end of the dosing interval
Time Frame
Day 1, Day 3, and Day 5
Title
PK Parameter: Cmax of GS-441524
Description
Cmax is defined as the maximum observed plasma concentration of drug
Time Frame
Day 1, Day 3, and Day 5
Title
Proportion of Participants with Relapse of COVID-19 Symptoms by Day 29
Time Frame
Up to Day 29

10. Eligibility

Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Key Inclusion Criteria: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection confirmed, ≤ 3 days before randomization, by polymerase chain reaction (PCR), rapid antigen test, or an approved alternative assay. Serologic tests will not be accepted. Willing and able to complete the coronavirus disease 19 (COVID-19) symptom questionnaire prior to first dose and daily throughout the study period. Initial onset of COVID-19 signs/symptoms ≤ 3 days before randomization with ≥ 2 of the following targeted symptoms, at moderate or higher severity, present at randomization. Stuffy or runny nose. Sore throat. Shortness of breath (difficulty breathing). Cough. Low energy or tiredness. Muscle or body aches. Headache. Chills or shivering. Feeling hot or feverish. Not currently hospitalized or requiring hospitalization. Key Exclusion Criteria: Any risk factors for progression to severe disease. Planning to receive a direct acting antiviral or monoclonal antibody against SARS-CoV-2 for the treatment of COVID-19. Received any direct acting antiviral drug or monoclonal antibody against SARS-CoV-2 for the treatment of COVID-19 < 28 days or < 5 half-lives, whichever is longer, before randomization. Received any convalescent COVID-19 plasma or other antibody-based anti-SARS-CoV-2 prophylaxis at any time prior to study entry. Received an COVID-19 vaccine (including booster dose) < 120 days before randomization. Self-reported COVID-19 diagnosis < 120 days before randomization. Anticipated need for hospitalization < 48 hours after randomization. New oxygen requirement < 24 hours before randomization. Known influenza, or any other suspected or confirmed concurrent active systemic infection other than COVID-19 that may interfere with the evaluation of response to the study drug. Known history of chronic liver disease, limited to cirrhosis, nonalcoholic steatohepatitis, alcoholic liver disease, and autoimmune hepatitis. Undergoing dialysis, or known history of chronic kidney disease. Persistent symptoms from previous COVID-19 illness that may interfere with the evaluation of response to the study drug. Pregnant or breastfeeding. Unwilling to use protocol-mandated contraception. Any other factor, including inability to complete the patient-reported outcome (PRO) questionnaire for the primary endpoint, making the individual, in the opinion of the investigator, unsuitable to participate in the study. Concurrent participation/enrollment in a separate therapeutic clinical study. Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Gilead Clinical Study Information Center
Phone
1-833-445-3230 (GILEAD-0)
Email
GileadClinicalTrials@gilead.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gilead Study Director
Organizational Affiliation
Gilead Sciences
Official's Role
Study Director
Facility Information:
Facility Name
EmVenio Research
City
Alabaster
State/Province
Alabama
ZIP/Postal Code
35007
Country
United States
Individual Site Status
Completed
Facility Name
Cullman Clinical Trials
City
Cullman
State/Province
Alabama
ZIP/Postal Code
35055
Country
United States
Individual Site Status
Withdrawn
Facility Name
Velocity Clinical Research
City
Mobile
State/Province
Alabama
ZIP/Postal Code
36608
Country
United States
Individual Site Status
Withdrawn
Facility Name
Cahaba Research, Inc.
City
Pelham
State/Province
Alabama
ZIP/Postal Code
35124
Country
United States
Individual Site Status
Withdrawn
Facility Name
Institute for Liver Health dba Arizona Clinical Trials
City
Chandler
State/Province
Arizona
ZIP/Postal Code
85224
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Absolute Clinical Research
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85051
Country
United States
Individual Site Status
Withdrawn
Facility Name
Headlands Research - Scottsdale
City
Scottsdale
State/Province
Arizona
ZIP/Postal Code
85260
Country
United States
Individual Site Status
Withdrawn
Facility Name
Epic Medical Research-Surprise
City
Surprise
State/Province
Arizona
ZIP/Postal Code
85378
Country
United States
Individual Site Status
Withdrawn
Facility Name
The Institute for Liver Health dba Arizona Liver Health
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85712
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Advanced Research Center, Inc.
City
Anaheim
State/Province
California
ZIP/Postal Code
92805
Country
United States
Individual Site Status
Withdrawn
Facility Name
Franco Felizarta, MD
City
Bakersfield
State/Province
California
ZIP/Postal Code
93301
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Velocity Clinical Research, Banning (IP Delivery and Administering Location)
City
Banning
State/Province
California
ZIP/Postal Code
92220
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Benchmark Research
City
Colton
State/Province
California
ZIP/Postal Code
92324
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
El Centro Regional Medical Center
City
El Centro
State/Province
California
ZIP/Postal Code
92243
Country
United States
Individual Site Status
Withdrawn
Facility Name
Ascada Research
City
Fullerton
State/Province
California
ZIP/Postal Code
92835
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Velocity Clinical Research
City
La Mesa
State/Province
California
ZIP/Postal Code
91942
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
IMAX Clinical Trials, LLC
City
La Palma
State/Province
California
ZIP/Postal Code
90623
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Om Research LLC
City
Lancaster
State/Province
California
ZIP/Postal Code
93534
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Biopharma Informatic, LLC
City
Los Angeles
State/Province
California
ZIP/Postal Code
90035
Country
United States
Individual Site Status
Withdrawn
Facility Name
Ruane Clinical Research Group Inc.
City
Los Angeles
State/Province
California
ZIP/Postal Code
90036
Country
United States
Individual Site Status
Withdrawn
Facility Name
L.A. Universal Research Center, INC.
City
Los Angeles
State/Province
California
ZIP/Postal Code
90057
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Amicis Research Center
City
Northridge
State/Province
California
ZIP/Postal Code
91324
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Valley Clinical Trials
City
Northridge
State/Province
California
ZIP/Postal Code
91325
Country
United States
Individual Site Status
Recruiting
Facility Name
Fomat Medical Research
City
Oxnard
State/Province
California
ZIP/Postal Code
93030
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Paradigm Clinical Research
City
Redding
State/Province
California
ZIP/Postal Code
96001
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Clinica de Salud del Valle de Salinas
City
Salinas
State/Province
California
ZIP/Postal Code
93901
Country
United States
Individual Site Status
Withdrawn
Facility Name
CRMD Research
City
San Bernardino
State/Province
California
ZIP/Postal Code
92408
Country
United States
Individual Site Status
Withdrawn
Facility Name
Wr-Whcr, Llc
City
San Diego
State/Province
California
ZIP/Postal Code
92111
Country
United States
Individual Site Status
Withdrawn
Facility Name
Zuckerberg San Francisco General Hospital
City
San Francisco
State/Province
California
ZIP/Postal Code
94110
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Clearview Medical Research, LLC
City
Santa Clarita
State/Province
California
ZIP/Postal Code
91351
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
EmVenio Research
City
Santa Monica
State/Province
California
ZIP/Postal Code
90404
Country
United States
Individual Site Status
Completed
Facility Name
Med Partners, Inc. dba Premiere Medical Center of Burbank, Inc.
City
Toluca Lake
State/Province
California
ZIP/Postal Code
91602
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Georgetown University Medical Center
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20007
Country
United States
Individual Site Status
Recruiting
Facility Name
Encore Medical Research of Boynton Beach LLC
City
Boynton Beach
State/Province
Florida
ZIP/Postal Code
33436
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Palm Harbor Dermatology d/b/a TrueBlue Clinical Research
City
Brandon
State/Province
Florida
ZIP/Postal Code
33511
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Innovative Research of West Florida, Inc
City
Clearwater
State/Province
Florida
ZIP/Postal Code
33756
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Prestige Clinical Research Center Inc
City
Coral Gables
State/Province
Florida
ZIP/Postal Code
33134
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Beautiful Minds Clinical Research Center
City
Cutler Bay
State/Province
Florida
ZIP/Postal Code
33157
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Midland Florida Clinical Research Center, LLC
City
DeLand
State/Province
Florida
ZIP/Postal Code
32720
Country
United States
Individual Site Status
Withdrawn
Facility Name
Vital Care Research
City
Doral
State/Province
Florida
ZIP/Postal Code
33122
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
UHC Research, LLC
City
Doral
State/Province
Florida
ZIP/Postal Code
33126
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Proactive Clinical Research,LLC
City
Fort Lauderdale
State/Province
Florida
ZIP/Postal Code
33308
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Midway Immunology and Research Center
City
Fort Pierce
State/Province
Florida
ZIP/Postal Code
34982
Country
United States
Individual Site Status
Withdrawn
Facility Name
Evolution Clinical Trials, INC
City
Hialeah Gardens
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Qway Research LLC
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33010
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
AGA Clinical Trials
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33012
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Inpatient Research Clinic- Facility and Drug Shipment
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33013
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Research in Miami
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33013
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
3Sync, LLC
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Best Quality Research, Inc.
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Doral Medical Research
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Innovative Health
City
Hollywood
State/Province
Florida
ZIP/Postal Code
33024
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Encore Medical Research, LLC
City
Hollywood
State/Province
Florida
ZIP/Postal Code
33201
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Wr-Msra, Llc
City
Lake City
State/Province
Florida
ZIP/Postal Code
32055
Country
United States
Individual Site Status
Withdrawn
Facility Name
Clinical Site Partners, LLC dba Flourish Research
City
Leesburg
State/Province
Florida
ZIP/Postal Code
34748
Country
United States
Individual Site Status
Withdrawn
Facility Name
Pro-Care Research Center, Corp.
City
Miami Gardens
State/Province
Florida
ZIP/Postal Code
33014
Country
United States
Individual Site Status
Withdrawn
Facility Name
Essential Clinical Research
City
Miami Lakes
State/Province
Florida
ZIP/Postal Code
33014
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Palm Springs Community Health Center
City
Miami Lakes
State/Province
Florida
ZIP/Postal Code
33014
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Angels Clinical Research Institute
City
Miami Lakes
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Quality Research of South Florida
City
Miami Lakes
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Advance Clinical Research Group
City
Miami
State/Province
Florida
ZIP/Postal Code
33122
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Med-Care Research, Corp
City
Miami
State/Province
Florida
ZIP/Postal Code
33125
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Southern Clinical Research LLC
City
Miami
State/Province
Florida
ZIP/Postal Code
33125
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
LCC Medical Research Institute, LLC
City
Miami
State/Province
Florida
ZIP/Postal Code
33126
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Universal Medical and Research Center, LLC.
City
Miami
State/Province
Florida
ZIP/Postal Code
33126
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
CCM Clinical Research Group, LLC
City
Miami
State/Province
Florida
ZIP/Postal Code
33133
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Global Health Clinical Trials Corp
City
Miami
State/Province
Florida
ZIP/Postal Code
33135
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Retreat Medical Research
City
Miami
State/Province
Florida
ZIP/Postal Code
33135
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Verus Clinical Research, Corp
City
Miami
State/Province
Florida
ZIP/Postal Code
33135
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Clinical Trial Services, Corp
City
Miami
State/Province
Florida
ZIP/Postal Code
33144
Country
United States
Individual Site Status
Recruiting
Facility Name
Continental Clinical Research
City
Miami
State/Province
Florida
ZIP/Postal Code
33144
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Dynamic Medical Research, LLC
City
Miami
State/Province
Florida
ZIP/Postal Code
33144
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Nuren Medical & Research Center
City
Miami
State/Province
Florida
ZIP/Postal Code
33144
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Advanced Care and Clinical Trials, LLC
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Bioclinical Research Alliance Inc.
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Cordova Research Institute, Inc
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
D&H National Research Centers, INC
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Florida International Medical Research
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Miami Clinical Research
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Allied Biomedical Research Institute
City
Miami
State/Province
Florida
ZIP/Postal Code
33166
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Diverse Clinical Research, LLC
City
Miami
State/Province
Florida
ZIP/Postal Code
33175
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
P&S Research, LLC.
City
Miami
State/Province
Florida
ZIP/Postal Code
33175
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
ProLive Medical Research, Corp
City
Miami
State/Province
Florida
ZIP/Postal Code
33175
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Entrust Clinical Research
City
Miami
State/Province
Florida
ZIP/Postal Code
33176
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Links Clinical Trials LLC
City
Miami
State/Province
Florida
ZIP/Postal Code
33176
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Reed Medical Research Corp
City
Miami
State/Province
Florida
ZIP/Postal Code
33176
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
MedBio Trials LLC
City
Miami
State/Province
Florida
ZIP/Postal Code
33180
Country
United States
Individual Site Status
Completed
Facility Name
Clinical Site Partners, LLC dba Flourish Research
City
Miami
State/Province
Florida
ZIP/Postal Code
33186
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Nuovida Research Center Corp
City
Miami
State/Province
Florida
ZIP/Postal Code
33186
Country
United States
Individual Site Status
Withdrawn
Facility Name
Phoenix Research Center, LLC
City
Miami
State/Province
Florida
ZIP/Postal Code
33186
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Oceanic Research Group
City
North Miami Beach
State/Province
Florida
ZIP/Postal Code
33169
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Accel Research Sites Network - St. Pete-Largo Clinical Research Unit
City
Orange City
State/Province
Florida
ZIP/Postal Code
32763
Country
United States
Individual Site Status
Withdrawn
Facility Name
Digestive and Liver Center of Florida
City
Orlando
State/Province
Florida
ZIP/Postal Code
32819
Country
United States
Individual Site Status
Withdrawn
Facility Name
Ormond Beach Clinical Research
City
Ormond Beach
State/Province
Florida
ZIP/Postal Code
32174
Country
United States
Individual Site Status
Withdrawn
Facility Name
Castillo Torres, MD PA
City
Palm Springs
State/Province
Florida
ZIP/Postal Code
33406
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Family Clinical Trials, LLC
City
Pembroke Pines
State/Province
Florida
ZIP/Postal Code
33026
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
USPA Advance Concept Medical Research Group, LLC
City
South Miami
State/Province
Florida
ZIP/Postal Code
33143
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Precision Clinical Research
City
Sunrise
State/Province
Florida
ZIP/Postal Code
33351
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Angels Clinical Research Institute
City
Tampa
State/Province
Florida
ZIP/Postal Code
33614
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Precision Research Center
City
Tampa
State/Province
Florida
ZIP/Postal Code
33614
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Santos Research Center, CORP
City
Tampa
State/Province
Florida
ZIP/Postal Code
33615
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Midway Specialty Care Center
City
West Palm Beach
State/Province
Florida
ZIP/Postal Code
33401
Country
United States
Individual Site Status
Withdrawn
Facility Name
Triple O Research Institute, P.A.
City
West Palm Beach
State/Province
Florida
ZIP/Postal Code
33407
Country
United States
Individual Site Status
Withdrawn
Facility Name
Encore Medical Reseach of Weston, LLC
City
Weston
State/Province
Florida
ZIP/Postal Code
33331
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Clinical Site Partners, LLC dba Flourish Research
City
Winter Park
State/Province
Florida
ZIP/Postal Code
32789
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
EmVenio Research
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30315
Country
United States
Individual Site Status
Completed
Facility Name
Agile Clinical Research Trials, LLC
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30328
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Covenant Pulmonary Critical Care Research Institute
City
East Point
State/Province
Georgia
ZIP/Postal Code
30344
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Accel Research Sites Network - Cardiology Care Clinic
City
Eatonton
State/Province
Georgia
ZIP/Postal Code
31024
Country
United States
Individual Site Status
Withdrawn
Facility Name
Velocity Clinical Research
City
Boise
State/Province
Idaho
ZIP/Postal Code
83642
Country
United States
Individual Site Status
Withdrawn
Facility Name
Metro Infectious Disease Consultants
City
Burr Ridge
State/Province
Illinois
ZIP/Postal Code
60527
Country
United States
Individual Site Status
Withdrawn
Facility Name
MediSphere Medical Research Center, LLC
City
Evansville
State/Province
Indiana
ZIP/Postal Code
47714
Country
United States
Individual Site Status
Withdrawn
Facility Name
Aliance for multispecialty Research, LLC
City
Lexington
State/Province
Kentucky
ZIP/Postal Code
40509
Country
United States
Individual Site Status
Withdrawn
Facility Name
Velocity Clinical Research
City
Covington
State/Province
Louisiana
ZIP/Postal Code
70433
Country
United States
Individual Site Status
Withdrawn
Facility Name
Velocity Clinical Research
City
Lafayette
State/Province
Louisiana
ZIP/Postal Code
70508
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Tulane University School of Medicine
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70112
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Velocity Clinical Research
City
Slidell
State/Province
Louisiana
ZIP/Postal Code
70458
Country
United States
Individual Site Status
Withdrawn
Facility Name
Velocity Clinical Research
City
Rockville
State/Province
Maryland
ZIP/Postal Code
20854
Country
United States
Individual Site Status
Withdrawn
Facility Name
Headlands Research
City
Southfield
State/Province
Michigan
ZIP/Postal Code
48034
Country
United States
Individual Site Status
Withdrawn
Facility Name
Hannibal Regional Healthcare System, Inc.
City
Hannibal
State/Province
Missouri
ZIP/Postal Code
63401
Country
United States
Individual Site Status
Withdrawn
Facility Name
Mercury Street Medical Group LLC
City
Butte
State/Province
Montana
ZIP/Postal Code
59701
Country
United States
Individual Site Status
Withdrawn
Facility Name
Velocity Clinical Research, Inc.
City
Lincoln
State/Province
Nebraska
ZIP/Postal Code
68510
Country
United States
Individual Site Status
Withdrawn
Facility Name
Saint Michael's Medical Center
City
Newark
State/Province
New Jersey
ZIP/Postal Code
07102
Country
United States
Individual Site Status
Withdrawn
Facility Name
Velocity Clinical Research
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87012
Country
United States
Individual Site Status
Withdrawn
Facility Name
University of New Mexico Health Sciences Center
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87131
Country
United States
Individual Site Status
Withdrawn
Facility Name
Lincoln Hospital
City
Bronx
State/Province
New York
ZIP/Postal Code
10451
Country
United States
Individual Site Status
Withdrawn
Facility Name
Prime Global Research Inc
City
Bronx
State/Province
New York
ZIP/Postal Code
10456
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
James J. Peters VA Medical Center
City
Bronx
State/Province
New York
ZIP/Postal Code
10468
Country
United States
Individual Site Status
Withdrawn
Facility Name
Velocity Clinical Research
City
East Syracuse
State/Province
New York
ZIP/Postal Code
13057
Country
United States
Individual Site Status
Withdrawn
Facility Name
Icahn School of Medicine at Mount Sinai
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States
Individual Site Status
Withdrawn
Facility Name
Velocity Clinical Research, Inc.
City
Vestal
State/Province
New York
ZIP/Postal Code
13850
Country
United States
Individual Site Status
Withdrawn
Facility Name
Velocity Clinical Research
City
Anderson
State/Province
North Carolina
ZIP/Postal Code
29621
Country
United States
Individual Site Status
Withdrawn
Facility Name
Shelby Clinical Research, LLC
City
Denver
State/Province
North Carolina
ZIP/Postal Code
28037
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
The Brody School of Medicine at East Carolina University
City
Greenville
State/Province
North Carolina
ZIP/Postal Code
27834
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Monroe Biomedical Research
City
Monroe
State/Province
North Carolina
ZIP/Postal Code
28112
Country
United States
Individual Site Status
Withdrawn
Facility Name
M3 Wake Research, Inc.
City
Raleigh
State/Province
North Carolina
ZIP/Postal Code
27612
Country
United States
Individual Site Status
Withdrawn
Facility Name
Carolina Research Center, Inc.
City
Shelby
State/Province
North Carolina
ZIP/Postal Code
28150
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Atrium Health Wake Forest Baptist
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27157
Country
United States
Individual Site Status
Withdrawn
Facility Name
The Lindner Research Center at The Christ Hospital
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45219
Country
United States
Individual Site Status
Withdrawn
Facility Name
STAT Research
City
Vandalia
State/Province
Ohio
ZIP/Postal Code
45377
Country
United States
Individual Site Status
Withdrawn
Facility Name
Velocity Clinical Research
City
Grants Pass
State/Province
Oregon
ZIP/Postal Code
97527
Country
United States
Individual Site Status
Withdrawn
Facility Name
Frontier Clinical Research, LLC
City
Smithfield
State/Province
Pennsylvania
ZIP/Postal Code
15478
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Velocity Clinical Research
City
Greenville
State/Province
South Carolina
ZIP/Postal Code
29615
Country
United States
Individual Site Status
Withdrawn
Facility Name
Clinovacare Medical Research Center
City
West Columbia
State/Province
South Carolina
ZIP/Postal Code
29169
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
WR-ClinSearch, LLC
City
Chattanooga
State/Province
Tennessee
ZIP/Postal Code
37421
Country
United States
Individual Site Status
Withdrawn
Facility Name
PharmaTex Research
City
Amarillo
State/Province
Texas
ZIP/Postal Code
79109
Country
United States
Individual Site Status
Withdrawn
Facility Name
Central Texas Clinical Research
City
Austin
State/Province
Texas
ZIP/Postal Code
78705
Country
United States
Individual Site Status
Withdrawn
Facility Name
St Hope Foundation, Inc.
City
Bellaire
State/Province
Texas
ZIP/Postal Code
77401
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
PanAmerican Clinical Research
City
Brownsville
State/Province
Texas
ZIP/Postal Code
78520
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Velocity Clinical Research
City
Cedar Park
State/Province
Texas
ZIP/Postal Code
78613
Country
United States
Individual Site Status
Withdrawn
Facility Name
WR-Global Medical Research, LLC
City
Dallas
State/Province
Texas
ZIP/Postal Code
75224
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Baylor University Medical Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75246
Country
United States
Individual Site Status
Withdrawn
Facility Name
Premier Pulmonary Critical Care and Sleep Medicine
City
Denison
State/Province
Texas
ZIP/Postal Code
75020
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Care United Research, LLC
City
Forney
State/Province
Texas
ZIP/Postal Code
75126
Country
United States
Individual Site Status
Withdrawn
Facility Name
EmVenio Research
City
Fort Worth
State/Province
Texas
ZIP/Postal Code
26134
Country
United States
Individual Site Status
Completed
Facility Name
Trio Clinical Trials, LLC.
City
Houston
State/Province
Texas
ZIP/Postal Code
77008
Country
United States
Individual Site Status
Withdrawn
Facility Name
HDH Research Inc.
City
Houston
State/Province
Texas
ZIP/Postal Code
77022
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Synergy Groups Medical LLC
City
Houston
State/Province
Texas
ZIP/Postal Code
77036
Country
United States
Individual Site Status
Withdrawn
Facility Name
Diversified Medical Practices
City
Houston
State/Province
Texas
ZIP/Postal Code
77057
Country
United States
Individual Site Status
Withdrawn
Facility Name
Next Level Urgent Care
City
Houston
State/Province
Texas
ZIP/Postal Code
77057
Country
United States
Individual Site Status
Withdrawn
Facility Name
Synergy Groups Medical LLC
City
Houston
State/Province
Texas
ZIP/Postal Code
77061
Country
United States
Individual Site Status
Withdrawn
Facility Name
The Crofoot Research Center, INC.
City
Houston
State/Province
Texas
ZIP/Postal Code
77098
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Zion Research/Zion Urgent Care Clinic
City
Katy
State/Province
Texas
ZIP/Postal Code
77494
Country
United States
Individual Site Status
Withdrawn
Facility Name
Milton Haber, MD
City
Laredo
State/Province
Texas
ZIP/Postal Code
78041
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
SMS Clinical Research, LLC
City
Mesquite
State/Province
Texas
ZIP/Postal Code
75149
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Synergy Groups Medical LLC
City
Missouri City
State/Province
Texas
ZIP/Postal Code
77459
Country
United States
Individual Site Status
Withdrawn
Facility Name
Village Health Partners
City
Plano
State/Province
Texas
ZIP/Postal Code
75024
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Village Health Partners
City
Plano
State/Province
Texas
ZIP/Postal Code
75025
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
North Texas Family Medicine
City
Plano
State/Province
Texas
ZIP/Postal Code
75093
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Epic Medical Research, LLC
City
Red Oak
State/Province
Texas
ZIP/Postal Code
75154
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
STAAMP Research LLC
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
VIP Trials
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78230
Country
United States
Individual Site Status
Withdrawn
Facility Name
ClinPoint Trials, LLC
City
Waxahachie
State/Province
Texas
ZIP/Postal Code
75165
Country
United States
Individual Site Status
Withdrawn
Facility Name
Tranquil Clinical Research
City
Webster
State/Province
Texas
ZIP/Postal Code
77598
Country
United States
Individual Site Status
Enrolling by invitation
Facility Name
Bountiful Internal Medicine
City
Bountiful
State/Province
Utah
ZIP/Postal Code
84010
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Velocity Clinical Research, Salt Lake City
City
West Jordan
State/Province
Utah
ZIP/Postal Code
84088
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Alliance for Multispecialty Research, LLC
City
Norfolk
State/Province
Virginia
ZIP/Postal Code
23502
Country
United States
Individual Site Status
Withdrawn
Facility Name
Frontier Clinical Research, LLC
City
Kingwood
State/Province
West Virginia
ZIP/Postal Code
26537
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Hamilton Medical Research Group
City
Hamilton
ZIP/Postal Code
L8M 1K7
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Kanagawa Himawari Clinic
City
Kawasaki-Shi
ZIP/Postal Code
216-0006
Country
Japan
Individual Site Status
Recruiting
Facility Name
Medical corporation Shirayurikai Swing Nozaki Clinic
City
Musashino
ZIP/Postal Code
180-0022
Country
Japan
Individual Site Status
Recruiting
Facility Name
Sato Clinic
City
Shibuya-ku
ZIP/Postal Code
150-0013
Country
Japan
Individual Site Status
Recruiting
Facility Name
Tokyo Shinagawa Hospital Social Medical Corporation Association Tokyokyojuno-kai
City
Shinagawa-Ku
ZIP/Postal Code
140-8522
Country
Japan
Individual Site Status
Recruiting
Facility Name
Proyecto ACTU
City
San Juan
ZIP/Postal Code
00935
Country
Puerto Rico
Individual Site Status
Not yet recruiting

12. IPD Sharing Statement

Plan to Share IPD
No
Links:
URL
https://www.gileadclinicaltrials.com/study/?id=GS-US-611-6549
Description
Gilead Clinical Trials Website

Learn more about this trial

Study of Obeldesivir in Nonhospitalized Participants With COVID-19

We'll reach out to this number within 24 hrs